MENU
+Compare
IBBQ
ETF ticker: NASDAQ
AS OF
Apr 23 closing price
Price
$20.50
Change
+$0.33 (+1.64%)
Net Assets
35.61M

IBBQ stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®... Show more

Category: #Health
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for IBBQ with price predictions
Apr 23, 2025

IBBQ in downward trend: price dove below 50-day moving average on March 25, 2025

IBBQ moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend. In of 28 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for IBBQ crossed bearishly below the 50-day moving average on March 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBBQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IBBQ entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IBBQ's RSI Oscillator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on IBBQ as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IBBQ just turned positive on April 17, 2025. Looking at past instances where IBBQ's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBBQ advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

IBBQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Nasdaq Biotechnology ETF ETF is 5.23B. The market cap for tickers in the group ranges from 23.05M to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is QTTB at 23.05M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 4%. For the same ETF, the average monthly price growth was -9%, and the average quarterly price growth was -12%. STRO experienced the highest price growth at 67%, while YMAB experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 22%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was 38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 78
Price Growth Rating: 69
SMR Rating: 85
Profit Risk Rating: 87
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
PowerShares Exchange-Traded Fund Tr II301 West Roosevelt RoadWheaton
Phone
N/A
Web
www.invescopowershares.com